Form 4: Nutex Health Inc. Director Granted RSUs

Nutex Health Inc. director Cheryl Yvonne Grenas was granted 823 Restricted Stock Units (RSUs) on April 23, 2026, vesting fully on April 23, 2027.

Summary

• Cheryl Yvonne Grenas, a director at Nutex Health Inc., received a grant of 823 Restricted Stock Units (RSUs) on April 23, 2026.
• These RSUs are set to vest 100% on April 23, 2027.
• In the event the reporting person leaves the company without cause during the vesting period, the RSUs will vest on a pro-rata basis.
• The RSUs represent a contingent right to receive one share of Nutex Health Inc.'s common stock upon vesting.
• Following the transaction, Ms. Grenas beneficially owns 1,426 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents standard director compensation and does not contain operational or financial results. The equity grant implies confidence in future performance.

Positives

• Director compensation through equity awards indicates management's commitment to aligning executive interests with shareholder value.
• The grant of RSUs suggests a positive outlook on the company's future performance, as their value is tied to stock appreciation.
• The vesting schedule encourages long-term commitment from the director.

Negatives

• The filing does not contain any negative financial or operational information.

Risks

• The value of the RSUs is subject to market fluctuations and the company's stock performance.
• If the reporting person leaves the company without cause before the vesting date, the RSUs will vest on a pro-rata basis, potentially reducing the ultimate award.

Future Outlook

The grant of RSUs with a one-year vesting period suggests a positive outlook for the company's stock performance over the next year, as the director's compensation is tied to this performance.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare and technology sectors, aligning leadership incentives with shareholder returns. This type of award is standard for retaining and motivating key personnel within publicly traded companies.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns director incentives with shareholder interests, potentially leading to decisions that enhance stock value.
• Employees: Standard compensation practices can contribute to a stable and motivated management team.
• Management: The award serves as a retention tool and performance incentive for the director.

Next Steps

• Vesting of 823 RSUs on April 23, 2027, contingent on continued service.
• Pro-rata vesting of RSUs if the reporting person leaves the company without cause during the vesting period.

Key Dates

Keywords

Nutex Health Inc., NUTX, Form 4, SEC Filing, Restricted Stock Units, RSUs, Director Compensation, Equity Award, Beneficial Ownership, Cheryl Yvonne Grenas